Biochemical modulation of 5-fluorouracil by PALA.
作者信息
O'Dwyer P J
机构信息
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
出版信息
Cancer Invest. 1990;8(2):261-2. doi: 10.3109/07357909009017577.
PMID:2400945
Abstract
摘要
相似文献
1
Biochemical modulation of 5-fluorouracil by PALA.
Cancer Invest. 1990;8(2):261-2. doi: 10.3109/07357909009017577.
2
Sparfosate. A novel biomodulator of 5-fluorouracil.
Cancer Pract. 1999 Jul-Aug;7(4):212-6. doi: 10.1046/j.1523-5394.1999.74011.x.
3
Role of thymidine in biochemical modulation: a review.
Cancer Res. 1987 Aug 1;47(15):3911-9.
4
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
Med Oncol. 1995 Sep;12(3):187-201. doi: 10.1007/BF01571196.
5
Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
Cancer Invest. 1990;8(2):263-4. doi: 10.3109/07357909009017578.
6
Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials.
Semin Oncol. 1992 Apr;19(2 Suppl 3):228-33.
7
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
J Infus Chemother. 1996 Fall;6(4):206-10.
8
Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
J Clin Oncol. 1992 May;10(5):747-52. doi: 10.1200/JCO.1992.10.5.747.
9
Biochemical modulation: a modality that has come of therapeutic age.
J Clin Oncol. 1991 Oct;9(10):1723-6. doi: 10.1200/JCO.1991.9.10.1723.
10
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer.
Invest New Drugs. 1997;15(2):139-45. doi: 10.1023/a:1005812923473.
引用本文的文献
1
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.
BMC Cancer. 2002 May 2;2:9. doi: 10.1186/1471-2407-2-9.
2
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group study.
Invest New Drugs. 1996;14(4):419-21. doi: 10.1007/BF00180821.
Zotero 插件